Matrix metalloproteinase-1 therapy improves muscle healing

Journal of Applied Physiology

Volumn 102, Issue 6, 2007, Pages 2338-2345

  Bedair, Hany ^a,b   Liu, T Thomas ^a,b   Kaar, Joel L ^c   Badlani, Shawn ^a   Russell, Alan J ^c   Li, Yong ^a,b,c   Huard, Johnny ^a,b,c,d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Fibrosis; Muscle injury; Regeneration

Indexed keywords

EOSIN; HEMATOXYLIN; INTERSTITIAL COLLAGENASE; M 1802; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HEALING; HISTOLOGY; LACZ GENE; MOUSE; MUSCLE INJURY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SCID MOUSE; STAINING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MICE, SCID; MUSCLE, SKELETAL; TREATMENT OUTCOME; WOUND HEALING; WOUNDS, PENETRATING;

EID: 34447544484     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00670.2006     Document Type: Article

References (27)

1. Almekinders LC. Anti-inflammatory treatment of muscular injuries in sports. Sports Med 15: 139-145, 1993.
2. Best TM, Hunter KD. Muscle injury and repair. Phys Med Rehabil Clin N Am 11: 251-266, 2000.
3. Best TM, Shehadeh SE, Leverson G, Michel JT, Corr DT, Aeschlimann D. Analysis of changes in mRNA levels of myoblast- and fibroblast-derived gene products in healing skeletal muscle using quantitative reverse transcription-polymerase chain reaction. J Orthop Res 19: 565-572, 2001.
4. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207-214, 2002.
5. Chan YS, Li Y, Foster W, Horaguchi T, Somogyi G, Fu FH, Huard J. Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 95: 771-780, 2003.
6. Dioszegi M, Cannon P, Van Wart HE. Vertebrate collagenases. Methods Enzymol 248: 413-431, 1995.
7. El Fahime E, Torrente Y, Caron NJ, Bresolin MD, Tremblay JP. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 258: 279-287, 2000.
8. Foster W, Li Y, Usas A, Somogyi G, Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res 21: 798-804, 2003.
9. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29: 394-402, 2001.
10. Hurme T, Kalimo H, Lehto M, Jarvinen M. Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. Med Sci Sports Exerc 23: 801-810, 1991.
11. Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, Choi SK, Brenner DA, Yamaoka Y. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124: 445-458, 2003.
12. Jarvinen MJ, Lehto MU. The effects of early mobilisation and immobilisation on the healing process following muscle injuries. Sports Med 15: 78-89, 1993.
13. Kalimo H, Rantanen J, Järvinen M. Muscle injuries in sports. Baillieres Clin Orthop 2: 1-24, 1997.
14. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, Fardeau M, Alameddine HS. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 205: 158-170, 1999.
15. Lewis MP, Tippett HL, Sinanan AC, Morgan MJ, Hunt NP. Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures. J Muscle Res Cell Motil 21: 223-233, 2000.
16. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 164: 1007-1019, 2004.
17. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161: 895-907, 2002.
18. Negishi S, Li Y, Usas A, Fu FH, Huard J. The effect of relaxin treatment on skeletal muscle injuries. Am J Sports Med 33: 1816-1824, 2005.
19. Okamoto T, Akaike T, Suga M, Tanase S, Horie H, Miyajima S, Ando M, Ichinose Y, Maeda H. Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem 272: 6059-6066, 1997.
20. Orchard JW, Seward HG. AFL injury report 2003. J Sci Med Sport 7: 264-265, 2004.
21. Sanderson MP, Dempsey PJ, Dunbar AJ. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 24: 121-136, 2006.
22. Siller-Lopez F, Sandoval A, Salgado S, Salazar A, Bueno M, Garcia J, Vera J, Galvez J, Hernandez I, Ramos M, Aguilar-Cordova E, Armendariz-Borunda J. Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126: 1122-1133; discussion 1949, 2004.
23. Stricklin GP, Jeffrey JJ, Roswit WT, Eisen AZ. Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry 22: 61-68, 1983.
24. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
25. Woods C, Hawkins RD, Maltby S, Hulse M, Thomas A, Hodson A. The Football Association Medical Research Programme: an audit of injuries in professional football - analysis of hamstring injuries. Br J Sports Med 38: 36-41, 2004.
26. Worrell TW. Factors associated with hamstring injuries. An approach to treatment and preventative measures. Sports Med 17: 338-345, 1994.
27. Zhang Y, Gray RD. Characterization of folded, intermediate, and unfolded states of recombinant human interstitial collagenase. J Biol Chem 271: 8015-8021, 1996.